Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AtriCure, Inc.ATRC · Entity 2704 | Director | May 07, 2021 | May 11, 2021 |
| Paragon 28, Inc.FNA · Entity 80621 | Director | May 18, 2022 | May 20, 2022 |
| ViewRay, Inc.VRAY · Entity 111118 | Director | July 18, 2023 | July 20, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AtriCure, Inc.
Report date May 07, 2021 · Filed May 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,036 |
Ending reported balance
After 2021-05-10 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2021-05-07 · Exercise / conversion · Acquired 38,641 · Balance 79,677 Row 2 · 2021-05-07 · Sale · Disposed 38,641 · Balance 41,036 F1: This transaction was executed in multiple trades at prices ranging from $77.52 to $79.13 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2021-05-10 · Exercise / conversion · Acquired 4,631 · Balance 45,667 Row 4 · 2021-05-10 · Sale · Disposed 4,631 · Balance 41,036 F2: This transaction was executed in multiple trades at prices ranging from $76.00 to $76.84 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.98 · Expires 2023-09-03 | Direct | 11,359 |
Reported balance
After 2021-05-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-05-07 · Exercise / conversion · Disposed 38,641 · Balance 11,359 F3: These options were granted on September 3, 2013. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.98 · Expires 2023-09-03 | Direct | 6,728 |
Reported balance
After 2021-05-10 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-05-10 · Exercise / conversion · Disposed 4,631 · Balance 6,728 F3: These options were granted on September 3, 2013. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $77.52 to $79.13 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $76.00 to $76.84 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: These options were granted on September 3, 2013. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
Paragon 28, Inc.
Report date May 18, 2022 · Filed May 20, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,949 |
Reported balance
After 2022-05-18 transaction · row 1
1 source rowRow 1 · 2022-05-18 · Grant · Acquired 8,918 · Balance 15,949 F1: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) the first anniversary of grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the Reporting Person's continued service to the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) the first anniversary of grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the Reporting Person's continued service to the issuer.
ViewRay, Inc.
Report date July 18, 2023 · Filed July 20, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,591,615 |
Reported balance
After 2023-07-18 transaction · row 1
1 source rowRow 1 · 2023-07-18 · Sale · Disposed 2,408,747 · Balance 1,591,615 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.059 to $0.067, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range stated. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.059 to $0.067, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range stated.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SPECTRANETICS CORP
Report date August 09, 2017 · Filed August 11, 2017
Section 16 reporting ended · disclosed 2017-08-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| SPNC Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 1
1 source rowRow 1 · 2017-08-09 · Disposition to issuer · Disposed 269,027 · Balance 0 F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the shares described in Note 2 below was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes. F2: Includes 45,453 shares of Company common stock underlying performance stock units that were subject solely to service-based vesting conditions immediately prior to the Effective Time (as defined in the Merger Agreement) and that, pursuant to their terms upon consummation of the Merger Agreement, were treated as restricted stock units and were cancelled at the Effective Time and converted into the right to receive $38.50 per share in cash, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.63 · Expires 2021-08-10 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-09 · Disposition to issuer · Disposed 200,707 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.87 · Expires 2022-05-31 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-08-09 · Disposition to issuer · Disposed 100,000 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.44 · Expires 2023-07-10 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-08-09 · Disposition to issuer · Disposed 99,403 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.05 · Expires 2026-01-08 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-08-09 · Disposition to issuer · Disposed 100,675 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-08-09 · Disposition to issuer · Disposed 8,600 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-08-09 · Disposition to issuer · Disposed 1,936 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-08-09 · Disposition to issuer · Disposed 14,060 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-08-09 · Disposition to issuer · Disposed 16,611 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-08-09 · Disposition to issuer · Disposed 64,706 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-08-09 · Disposition to issuer · Disposed 206,498 · Balance 0 F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2017-08-09 · Disposition to issuer · Disposed 43,138 · Balance 0 F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the shares described in Note 2 below was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes.
F2: Includes 45,453 shares of Company common stock underlying performance stock units that were subject solely to service-based vesting conditions immediately prior to the Effective Time (as defined in the Merger Agreement) and that, pursuant to their terms upon consummation of the Merger Agreement, were treated as restricted stock units and were cancelled at the Effective Time and converted into the right to receive $38.50 per share in cash, without interest and less any required withholding taxes.
F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes.
F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes.
F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes.
Zayo Group Holdings, Inc.
Report date March 09, 2020 · Filed March 09, 2020
Section 16 reporting ended · disclosed 2020-03-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-03-09 transaction · row 1
1 source rowRow 1 · 2020-03-09 · Disposition to issuer · Disposed 10,430 · Balance 0 F1: On May 8, 2019, Zayo Group Holdings, Inc. (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among Front Range TopCo, Inc. ("Parent") and Front Range BidCo, Inc. ("Merger Sub"). On March 9, 2020, Merger Sub merged with any into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $35 (the "Merger Consideration"), without interest and not including any required withholding of taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-03-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-03-09 · Disposition to issuer · Disposed 1,911 · Balance 0 F2: Each unvested Part C RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes. F3: On January 6, 2020, the Reporting Person was granted the reported number of Part C RSUs that were unvested as of the closing of the Merger. Each such RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for each such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 8, 2019, Zayo Group Holdings, Inc. (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among Front Range TopCo, Inc. ("Parent") and Front Range BidCo, Inc. ("Merger Sub"). On March 9, 2020, Merger Sub merged with any into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $35 (the "Merger Consideration"), without interest and not including any required withholding of taxes.
F2: Each unvested Part C RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes.
F3: On January 6, 2020, the Reporting Person was granted the reported number of Part C RSUs that were unvested as of the closing of the Merger. Each such RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for each such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 18, 2023 Filed Jul 20, 2023 20:35 UTC | ViewRay, Inc. VRAY · Entity 111118 | SaleCommon Stock | 2,408,747 | $0.06 | $149,824.06 |
DisclosureSEC source: 0001628280-23-025275 · wk-form4_1689899716.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,591,615 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.059 to $0.067, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range stated. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 16:39 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 116,003 | $0.48 | $55,797.44 |
DisclosureSEC source: 0001628280-23-022485 · wk-form4_1686947950.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000,362 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 3,523,808 shares granted as RSUs. As of the transaction date, 2,408,747 of the RSUs have vested. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 17:23 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 37,321 | $4.25 | $158,614.25 |
DisclosureSEC source: 0001628280-23-006347 · wf-form4_167788219214372.xml · nonDerivative · entry 4 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,116,365 F2 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F3 · balance_after: Includes 3,523,808 shares granted as RSUs. As of the transaction date, 2,259,602 of the RSUs have vested. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 17:23 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock · Derivative | 483,870 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006347 · wf-form4_167788219214372.xml · derivative · entry 5 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,870 Underlying: Common Stock · 483,870 shares Expires not disclosed F4 · shares: These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled. F4 · derivative.exercise_date: These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled. F4 · derivative.expiration_date: These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 17:23 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 70,453 | $4.34 | $305,766.02 |
DisclosureSEC source: 0001628280-23-006347 · wf-form4_167788219214372.xml · nonDerivative · entry 3 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,153,686 F2 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 17:23 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 84,495 | $4.34 | $366,708.30 |
DisclosureSEC source: 0001628280-23-006347 · wf-form4_167788219214372.xml · nonDerivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,224,139 F2 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 17:23 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 483,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006347 · wf-form4_167788219214372.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,308,634 F1 · shares: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of March 1, 2023, subject to the Reporting Person remaining a service provider through each such vesting date. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 16:44 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 96,546 | $4.40 | $424,802.40 |
DisclosureSEC source: 0001628280-23-000248 · wf-form4_167286867285175.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,824,764 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 3,519,185 shares granted as RSUs. As of the transaction date, 2,202,835 of the RSUs have vested. Read SEC document |
| October 24, 2022 Filed Oct 25, 2022 16:12 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 74,032 | $4.16 | $307,973.12 |
DisclosureSEC source: 0001628280-22-026987 · wf-form4_166672876315712.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,921,310 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 3,519,185 shares granted as RSUs. As of the transaction date, 2,083,595 of the RSUs have vested. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 20:28 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 116,400 | $2.69 | $313,116.00 |
DisclosureSEC source: 0001628280-22-017393 · wf-form4_165542568260760.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,995,342 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 3,519,185 shares granted as RSUs. As of the transaction date, 1,914,959 of the RSUs have vested. Read SEC document |
| May 18, 2022 Filed May 20, 2022 17:07 UTC | Paragon 28, Inc. FNA · Entity 80621 | GrantCommon Stock | 8,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-011427 · doc1.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,949 F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) the first anniversary of grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the Reporting Person's continued service to the issuer. Read SEC document |
| May 11, 2022 Filed May 12, 2022 06:05 UTC | ViewRay, Inc. VRAY · Entity 111118 | PurchaseCommon Stock | 117,012 | $2.53 | $295,513.81 |
DisclosureSEC source: 0001628280-22-013938 · wf-form4_165234988159755.xml · nonDerivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,111,742 F2 · price: Reflects average weighted purchase price. Actual purchase prices ranged from $2.455 to $2.585 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 10, 2022 Filed May 12, 2022 06:05 UTC | ViewRay, Inc. VRAY · Entity 111118 | PurchaseCommon Stock | 40,000 | $2.61 | $104,480.00 |
DisclosureSEC source: 0001628280-22-013938 · wf-form4_165234988159755.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,994,730 F1 · price: Reflects average weighted purchase price. Actual purchase prices ranged from $2.515 to $2.695 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 19:18 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 37,449 | $4.24 | $158,783.76 |
DisclosureSEC source: 0001628280-22-005019 · wf-form4_164635304943026.xml · nonDerivative · entry 4 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,954,730 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F3 · balance_after: Includes 3,519,185 shares granted as RSUs. As of the transaction date, 1,649,811 of the RSUs have vested. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 19:18 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantPerformance Units · Derivative | 483,091 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-005019 · wf-form4_164635304943026.xml · derivative · entry 5 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,091 Underlying: Common Stock · 483,091 shares Expires not disclosed F4 · shares: These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled. F4 · derivative.exercise_date: These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled. F4 · derivative.expiration_date: These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 19:18 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 483,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-005019 · wf-form4_164635304943026.xml · nonDerivative · entry 3 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,992,179 F2 · shares: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of March 1, 2022, subject to the Reporting Person remaining a service provider through each such vesting date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 19:18 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 26,348 | $4.14 | $109,080.72 |
DisclosureSEC source: 0001628280-22-005019 · wf-form4_164635304943026.xml · nonDerivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,509,088 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 19:18 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 84,787 | $4.14 | $351,018.18 |
DisclosureSEC source: 0001628280-22-005019 · wf-form4_164635304943026.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,535,436 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. Read SEC document |
| January 02, 2022 Filed Jan 4, 2022 16:15 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 96,058 | $5.51 | $529,279.58 |
DisclosureSEC source: 0001628280-22-000178 · wf-form4_164133087558498.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,620,223 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 3,184,678 shares granted as RSUs. As of the transaction date, 1,459,939 of the RSUs have vested. Read SEC document |
| November 19, 2021 Filed Nov 19, 2021 11:42 UTC | ViewRay, Inc. VRAY · Entity 111118 | PurchaseCommon Stock | 89,285 | $5.60 | $499,996.00 |
DisclosureSEC source: 0001628280-21-023862 · wf-form4_163734012189299.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,716,281 Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 16:57 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 74,032 | $6.81 | $504,157.92 |
DisclosureSEC source: 0001628280-21-020540 · wf-form4_163528181045151.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,626,996 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 3,280,736 shares granted as RSUs. As of the transaction date, 1,340,210 of the RSUs have vested. Read SEC document |
| October 14, 2021 Filed Dec 3, 2021 16:28 UTC | Paragon 28, Inc. FNA · Entity 80621 | GrantCommon Stock | 7,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-021590 · doc1.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,031 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) the first anniversary of grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting Person's continued service to the issuer. F2 · balance_after: Includes 7,031 RSUs. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 16:05 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 169,016 | $6.53 | $1,103,674.48 |
DisclosureSEC source: 0001209191-21-048157 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,701,028 F1 · shares: Payment of tax liability by withholding securities incident to the vesting of restricted stock units. F2 · balance_after: Includes 3,354,768 shares granted as RSUs. As of the transaction date, 1,245,605 of the RSUs have vested. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 16:30 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 168,580 | $5.83 | $982,821.40 |
DisclosureSEC source: 0001209191-21-040917 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,870,044 F1 · shares: Payment of tax liability by withholding securities incident to the vesting of restricted stock units. F2 · balance_after: Includes 3,523,784 shares granted as RSUs. As of the transaction date, 1,029,621 of the RSUs have vested. Read SEC document |
| May 10, 2021 Filed May 11, 2021 12:46 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,631 | $0.00 Strike: $8.98 | $0.00 |
DisclosureSEC source: 0001209191-21-031479 · doc4.xml · derivative · entry 6 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,728 Underlying: Common Stock · 4,631 shares Expires 2023-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on September 3, 2013. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| May 10, 2021 Filed May 11, 2021 12:46 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 4,631 | $76.52 | $354,364.12 |
DisclosureSEC source: 0001209191-21-031479 · doc4.xml · nonDerivative · entry 4 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,036 F2 · price: This transaction was executed in multiple trades at prices ranging from $76.00 to $76.84 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 10, 2021 Filed May 11, 2021 12:46 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 4,631 | $8.98 | $41,586.38 |
DisclosureSEC source: 0001209191-21-031479 · doc4.xml · nonDerivative · entry 3 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 11, 2021 12:46 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,641 | $0.00 Strike: $8.98 | $0.00 |
DisclosureSEC source: 0001209191-21-031479 · doc4.xml · derivative · entry 5 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,359 Underlying: Common Stock · 38,641 shares Expires 2023-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on September 3, 2013. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| May 07, 2021 Filed May 11, 2021 12:46 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 38,641 | $77.90 | $3,010,133.90 |
DisclosureSEC source: 0001209191-21-031479 · doc4.xml · nonDerivative · entry 2 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,036 F1 · price: This transaction was executed in multiple trades at prices ranging from $77.52 to $79.13 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 07, 2021 Filed May 11, 2021 12:46 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 38,641 | $8.98 | $346,996.18 |
DisclosureSEC source: 0001209191-21-031479 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 19:25 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 37,449 | $4.51 | $168,894.99 |
DisclosureSEC source: 0001209191-21-017347 · doc4.xml · nonDerivative · entry 3 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,038,624 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F3 · balance_after: Includes 3,692,364 shares granted as RSUs. As of the transaction date, 814,193 of the RSUs have vested. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 19:25 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantPerformance Units · Derivative | 285,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017347 · doc4.xml · derivative · entry 4 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,275 Underlying: Common Stock · 285,375 shares Expires not disclosed F4 · shares: These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled. F4 · derivative.exercise_date: These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled. F4 · derivative.expiration_date: These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 19:25 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 579,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017347 · doc4.xml · nonDerivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,076,073 F2 · shares: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of March 1, 2021, subject to the Reporting Person remaining a service provider through each such vesting date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 19:25 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 26,347 | $4.66 | $122,777.02 |
DisclosureSEC source: 0001209191-21-017347 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,496,674 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. Read SEC document |
| January 02, 2021 Filed Jan 4, 2021 08:14 UTC Amendment | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 139,289 | $3.82 | $532,083.98 |
DisclosureSEC source: 0001209191-21-000005 · doc4a.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,523,021 F1 · date: This Form 4/A amends and restates the Form 4 filed on January 4, 2021 which reported the transaction date as January 2, 2020 instead of January 2, 2021 for the reported transaction. The correct date for the reported transaction is presented above. F2 · kind: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F3 · balance_after: Includes 3,176,761 shares granted as RSUs. As of the transaction date, 732,671 of the RSUs have vested. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 12:40 UTC | AtriCure, Inc. ATRC · Entity 2704 | PurchaseCommon Stock | 12,350 | $40.54 | $500,669.00 |
DisclosureSEC source: 0001209191-20-059309 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,036 F1 · price: This transaction was executed in multiple trades at prices ranging from $40.48 to $40.61 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 08:17 UTC | ViewRay, Inc. VRAY · Entity 111118 | PurchaseCommon Stock | 155,000 | $3.23 | $499,906.00 |
DisclosureSEC source: 0001209191-20-057827 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,662,310 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.06 to $3.35, inclusive. The reporting person undertakes to provide to ViewRay, Inc., any security holder of ViewRay, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote. F2 · balance_after: Includes 3,316,050 shares granted as RSUs. As of the transaction date, 559,442 of the RSUs have vested. Read SEC document |
| October 24, 2020 Filed Oct 27, 2020 17:19 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 74,167 | $3.05 | $226,209.35 |
DisclosureSEC source: 0001209191-20-055937 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,507,310 F1 · kind: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 3,316,050 shares granted as RSUs. As of the transaction date, 559,442 of the RSUs have vested. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 17:08 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 169,323 | $2.45 | $414,841.35 |
DisclosureSEC source: 0001209191-20-043626 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,581,477 F1 · kind: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 3,390,217 shares granted as RSUs. As of the transaction date, 464,973 of the RSUs have vested. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 18:05 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 914,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037378 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750,800 F1 · kind: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. The shares subject to this grant become vested as follows: 42% of the shares become vested on the first anniversary of June 15, 2020 and 29% of the shares become vested on the second and third anniversary of June 15, 2020, subject to the Reporting Person remaining a service provider through each such vesting date. F2 · balance_after: Includes 3,559,540 shares granted as RSUs. As of the transaction date, 249,296 of the RSUs have vested. Read SEC document |
| May 20, 2020 Filed May 22, 2020 12:16 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031552 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,686 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| March 09, 2020 Filed Mar 9, 2020 11:39 UTC | Zayo Group Holdings, Inc. ZAYO · Entity 150849 | Disposition to issuerRestricted Stock Units · Derivative | 1,911 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-017142 · doc4.xml · derivative · entry 2 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,911 shares Expires not disclosed F2 · derivative.exercise_price: Each unvested Part C RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes. F2 · kind: Each unvested Part C RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes. F3 · price: On January 6, 2020, the Reporting Person was granted the reported number of Part C RSUs that were unvested as of the closing of the Merger. Each such RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for each such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes. F3 · derivative.exercise_date: On January 6, 2020, the Reporting Person was granted the reported number of Part C RSUs that were unvested as of the closing of the Merger. Each such RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for each such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes. F3 · derivative.expiration_date: On January 6, 2020, the Reporting Person was granted the reported number of Part C RSUs that were unvested as of the closing of the Merger. Each such RSU held by the Reporting Person was converted into the right to receive the Merger Consideration for each such RSU, to be paid in full to the Reporting Person on March 31, 2020, without interest and not including any required withholding of taxes. Read SEC document |
| March 09, 2020 Filed Mar 9, 2020 11:39 UTC | Zayo Group Holdings, Inc. ZAYO · Entity 150849 | Disposition to issuerCommon Stock | 10,430 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-017142 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On May 8, 2019, Zayo Group Holdings, Inc. (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among Front Range TopCo, Inc. ("Parent") and Front Range BidCo, Inc. ("Merger Sub"). On March 9, 2020, Merger Sub merged with any into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $35 (the "Merger Consideration"), without interest and not including any required withholding of taxes. F1 · price: On May 8, 2019, Zayo Group Holdings, Inc. (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among Front Range TopCo, Inc. ("Parent") and Front Range BidCo, Inc. ("Merger Sub"). On March 9, 2020, Merger Sub merged with any into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $35 (the "Merger Consideration"), without interest and not including any required withholding of taxes. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 18:15 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 255,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015589 · doc4.xml · nonDerivative · entry 2 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,836,496 F2 · kind: A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of March 2, 2020, subject to the Reporting Person remaining a service provider through each such vesting date. F3 · balance_after: Includes 2,645,236 shares granted as RSUs. As of the transaction date, 249,296 of the RSUs have vested. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 18:15 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 26,396 | $2.87 | $75,756.52 |
DisclosureSEC source: 0001209191-20-015589 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,580,587 F1 · kind: Payment of tax liability by withholding securities incident to vesting of restricted stock units. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 18:09 UTC | Zayo Group Holdings, Inc. ZAYO · Entity 150849 | GrantRestricted Stock Units · Derivative | 1,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-002334 · doc4.xml · derivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,911 Underlying: Common Stock · 1,911 shares Expires not disclosed F1 · derivative.exercise_price: Each Part C restricted stock unit represents a contingent right to receive one share of Zayo Group Holdings, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on March 31, 2020. F2 · derivative.expiration_date: The restricted stock units vest in full on March 31, 2020. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 18:03 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 744,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-002070 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,606,983 F1 · kind: The shares subject to this grant become vested as follows: 42% of the shares become vested on the first anniversary of January 2, 2020 and 29% of the shares become vested on the second and third anniversary of January 2, 2020, subject to the Reporting Person remaining a service provider through each such vesting date. F2 · balance_after: Includes 2,415,723 shares granted as RSUs. As of the transaction date, 215,676 of the RSUs have vested. Read SEC document |
| January 02, 2020 Filed Jan 4, 2021 07:54 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 139,289 | $3.82 | $532,083.98 |
DisclosureSEC source: 0001209191-21-000003 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,523,021 F1 · kind: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 3,176,761 shares granted as RSUs. As of the transaction date, 732,671 of the RSUs have vested. Read SEC document |
| December 31, 2019 Filed Jan 6, 2020 16:40 UTC | Zayo Group Holdings, Inc. ZAYO · Entity 150849 | Exercise / conversionRestricted Stock units · Derivative | 1,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-001868 · doc4.xml · derivative · entry 2 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,947 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Part C restricted stock unit converted into one share of Zayo Group Holdings, Inc. common stock. F2 · derivative.exercise_date: On October 4, 2019 the reporting person was granted Part C restricted stock units, which vested in full on December 31, 2019. F2 · derivative.expiration_date: On October 4, 2019 the reporting person was granted Part C restricted stock units, which vested in full on December 31, 2019. Read SEC document |
| December 31, 2019 Filed Jan 6, 2020 16:40 UTC | Zayo Group Holdings, Inc. ZAYO · Entity 150849 | Exercise / conversionCommon Stock | 1,947 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-001868 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Part C restricted stock unit converted into one share of Zayo Group Holdings, Inc. common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.